These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
314 related articles for article (PubMed ID: 31445775)
1. The emerging role of exosomes in multiple myeloma. Moloudizargari M; Abdollahi M; Asghari MH; Zimta AA; Neagoe IB; Nabavi SM Blood Rev; 2019 Nov; 38():100595. PubMed ID: 31445775 [TBL] [Abstract][Full Text] [Related]
2. Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes. Frassanito MA; Desantis V; Di Marzo L; Craparotta I; Beltrame L; Marchini S; Annese T; Visino F; Arciuli M; Saltarella I; Lamanuzzi A; Solimando AG; Nico B; De Angelis M; Racanelli V; Mariggiò MA; Chiacchio R; Pizzuti M; Gallone A; Fumarulo R; D'Incalci M; Vacca A J Pathol; 2019 Feb; 247(2):241-253. PubMed ID: 30357841 [TBL] [Abstract][Full Text] [Related]
3. MicroRNAs and exosomes: Small molecules with big actions in multiple myeloma pathogenesis. Pourhanifeh MH; Mahjoubin-Tehran M; Shafiee A; Hajighadimi S; Moradizarmehri S; Mirzaei H; Asemi Z IUBMB Life; 2020 Mar; 72(3):314-333. PubMed ID: 31828868 [TBL] [Abstract][Full Text] [Related]
4. Long-chain polyunsaturated omega-3 fatty acids reduce multiple myeloma exosome-mediated suppression of NK cell cytotoxicity. Moloudizargari M; Redegeld F; Asghari MH; Mosaffa N; Mortaz E Daru; 2020 Dec; 28(2):647-659. PubMed ID: 32974883 [TBL] [Abstract][Full Text] [Related]
5. Exosome-derived miR-let-7c promotes angiogenesis in multiple myeloma by polarizing M2 macrophages in the bone marrow microenvironment. Tian X; Sun M; Wu H; Chen C; Li H; Qiu S; Wang T; Han J; Xiao Q; Chen K Leuk Res; 2021 Jun; 105():106566. PubMed ID: 33848709 [TBL] [Abstract][Full Text] [Related]
6. Recent Progress of Exosomes in Multiple Myeloma: Pathogenesis, Diagnosis, Prognosis and Therapeutic Strategies. Wang X; He L; Huang X; Zhang S; Cao W; Che F; Zhu Y; Dai J Cancers (Basel); 2021 Apr; 13(7):. PubMed ID: 33915822 [TBL] [Abstract][Full Text] [Related]
7. Induction of miR-146a by multiple myeloma cells in mesenchymal stromal cells stimulates their pro-tumoral activity. De Veirman K; Wang J; Xu S; Leleu X; Himpe E; Maes K; De Bruyne E; Van Valckenborgh E; Vanderkerken K; Menu E; Van Riet I Cancer Lett; 2016 Jul; 377(1):17-24. PubMed ID: 27102001 [TBL] [Abstract][Full Text] [Related]
8. ACE2-EPC-EXs protect ageing ECs against hypoxia/reoxygenation-induced injury through the miR-18a/Nox2/ROS pathway. Zhang C; Wang J; Ma X; Wang W; Zhao B; Chen Y; Chen C; Bihl JC J Cell Mol Med; 2018 Mar; 22(3):1873-1882. PubMed ID: 29363860 [TBL] [Abstract][Full Text] [Related]
9. Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring. He D; Wang H; Ho SL; Chan HN; Hai L; He X; Wang K; Li HW Theranostics; 2019; 9(15):4494-4507. PubMed ID: 31285775 [No Abstract] [Full Text] [Related]
10. Hypoxic BMSC-derived exosomal miRNAs promote metastasis of lung cancer cells via STAT3-induced EMT. Zhang X; Sai B; Wang F; Wang L; Wang Y; Zheng L; Li G; Tang J; Xiang J Mol Cancer; 2019 Mar; 18(1):40. PubMed ID: 30866952 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA Transfer Between Bone Marrow Adipose and Multiple Myeloma Cells. Soley L; Falank C; Reagan MR Curr Osteoporos Rep; 2017 Jun; 15(3):162-170. PubMed ID: 28432594 [TBL] [Abstract][Full Text] [Related]
12. [Clinical Study of miRNAs Derived from Serum Exosomes in Multiple Myeloma]. Zhou L; Liu XL; Li YW; Wu L; Wang GZ; Wang ZF; Ma L; Guan J; Han CX Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2022 Oct; 30(5):1490-1495. PubMed ID: 36208254 [TBL] [Abstract][Full Text] [Related]
13. Exosomes play a role in multiple myeloma bone disease and tumor development by targeting osteoclasts and osteoblasts. Faict S; Muller J; De Veirman K; De Bruyne E; Maes K; Vrancken L; Heusschen R; De Raeve H; Schots R; Vanderkerken K; Caers J; Menu E Blood Cancer J; 2018 Nov; 8(11):105. PubMed ID: 30409995 [TBL] [Abstract][Full Text] [Related]
14. Targeting of stromal versican by miR-144/199 inhibits multiple myeloma by downregulating FAK/STAT3 signalling. Gupta N; Kumar R; Seth T; Garg B; Sharma A RNA Biol; 2020 Jan; 17(1):98-111. PubMed ID: 31532704 [TBL] [Abstract][Full Text] [Related]
15. Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation. Raimondi L; De Luca A; Amodio N; Manno M; Raccosta S; Taverna S; Bellavia D; Naselli F; Fontana S; Schillaci O; Giardino R; Fini M; Tassone P; Santoro A; De Leo G; Giavaresi G; Alessandro R Oncotarget; 2015 May; 6(15):13772-89. PubMed ID: 25944696 [TBL] [Abstract][Full Text] [Related]
16. Potential role of exosome-associated microRNA panels and in vivo environment to predict drug resistance for patients with multiple myeloma. Zhang L; Pan L; Xiang B; Zhu H; Wu Y; Chen M; Guan P; Zou X; Valencia CA; Dong B; Li J; Xie L; Ma H; Wang F; Dong T; Shuai X; Niu T; Liu T Oncotarget; 2016 May; 7(21):30876-91. PubMed ID: 27129167 [TBL] [Abstract][Full Text] [Related]
17. Runx2 Suppression by miR-342 and miR-363 Inhibits Multiple Myeloma Progression. Gowda PS; Wildman BJ; Trotter TN; Xu X; Hao X; Hassan MQ; Yang Y Mol Cancer Res; 2018 Jul; 16(7):1138-1148. PubMed ID: 29592898 [TBL] [Abstract][Full Text] [Related]
18. Role of Acute Myeloid Leukemia (AML)-Derived exosomes in tumor progression and survival. Amin AH; Sharifi LMA; Kakhharov AJ; Opulencia MJC; Alsaikhan F; Bokov DO; Majdi HS; Jawad MA; Hammid AT; Shalaby MN; Mustafa YF; Siahmansouri H Biomed Pharmacother; 2022 Jun; 150():113009. PubMed ID: 35486974 [TBL] [Abstract][Full Text] [Related]
19. Loading MiR-210 in Endothelial Progenitor Cells Derived Exosomes Boosts Their Beneficial Effects on Hypoxia/Reoxygeneation-Injured Human Endothelial Cells via Protecting Mitochondrial Function. Ma X; Wang J; Li J; Ma C; Chen S; Lei W; Yang Y; Liu S; Bihl J; Chen C Cell Physiol Biochem; 2018; 46(2):664-675. PubMed ID: 29621777 [TBL] [Abstract][Full Text] [Related]
20. Targeting the miR-221-222/PUMA/BAK/BAX Pathway Abrogates Dexamethasone Resistance in Multiple Myeloma. Zhao JJ; Chu ZB; Hu Y; Lin J; Wang Z; Jiang M; Chen M; Wang X; Kang Y; Zhou Y; Ni Chonghaile T; Johncilla ME; Tai YT; Cheng JQ; Letai A; Munshi NC; Anderson KC; Carrasco RD Cancer Res; 2015 Oct; 75(20):4384-4397. PubMed ID: 26249174 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]